ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 39215 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 39215; 2) Community: the network communities that were significantly associated with the response to NSC 39215; 3) Molecule: the relationships between components within communities and NSC 39215; 4) MDR: the compounds that were significantly associated with the NSC 39215.

NSC Compound Enrichment Correlation
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.0385613993886001 0.62654451
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.0385613993886001 -0.015342774
NSC 703037 Null 0.0385613993886001 -0.0067305132
NSC 703105 Null 0.0385613993886001 0.33006442
NSC 707904 Null 0.0385613993886001 0.19541203
NSC 709483 Null 0.0385613993886001 0.17611983
NSC 716032 Null 0.0385613993886001 0.44197882
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0385613993886001 0.33697882
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0385613993886001 0.455465
NSC 740 Methotrexate 0.0385613993886001 0.18353075
Total:119  Current:101    [First] [Prev] [Next] [Last]